Electronically Connected Health Coaching in Type 2 Diabetes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02036892|
Recruitment Status : Unknown
Verified January 2014 by Paul Ritvo, York University.
Recruitment status was: Recruiting
First Posted : January 15, 2014
Last Update Posted : January 15, 2014
|Condition or disease||Intervention/treatment||Phase|
|Type 2 Diabetes||Behavioral: Lifestyle counseling with smartphone Behavioral: Lifestyle counseling||Phase 3|
Inclusion criteria: all participating patients have been diagnosed with Type 2 Diabetes, are between 25 and 70 years of age, have a regular primary care physician, and have HbA1c levels > or = to 7.3.
Exclusion criteria: Axis I and II psychiatric disorders.
Primary outcome: HBA1c at 6 months follow up.
Secondary outcome: Centre for Epidemiological Studies Depression Scale
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||115 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Electronically Connected Health Coaching in Improving Type 2 Diabetes Self Management - Phase III Trial|
|Study Start Date :||February 2012|
|Estimated Primary Completion Date :||May 2014|
|Estimated Study Completion Date :||June 2014|
Experimental: Lifestyle counseling with smartphones
Lifestyle counseling assisted by smartphones
Behavioral: Lifestyle counseling with smartphone
Lifestyle counseling with health promoting smartphone software
Active Comparator: Lifestyle counseling
Behavioral: Lifestyle counseling
- Hemoglobin A1c [ Time Frame: 6 months follow up from baseline ]Finger prick A1c test or lab test
- Center for Epidemiological Studies Depression Scale [ Time Frame: 6 months follow up from baseline assessment ]Self report measure of psychological distress
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02036892
|Contact: Paul Ritvo, PhDfirstname.lastname@example.org|
|Contact: Noah Wayne, MScemail@example.com|
|Black Creek Community Health Centre||Recruiting|
|Toronto, Ontario, Canada, M3M1A4|
|Contact: Paul Ritvo, PhD 4165808021 firstname.lastname@example.org|
|Contact: Noah Wayne, MSc 4168897289 NoahWayne@gmail.com|
|Sub-Investigator: Noah Wayne, MSc|
|Principal Investigator:||Paul Ritvo, PhD||York University|